Xu WH - Search Results

1

Pemetrexed in treating patients with metastatic bladder cancer.

Li Q, Li JZ, Xu WH, Gao L. Li Q, et al. Among authors: xu wh. Asian Pac J Cancer Prev. 2015;16(9):3839-41. doi: 10.7314/apjcp.2015.16.9.3839. Asian Pac J Cancer Prev. 2015. PMID: 25987046 Free article.

2

[Interferon-gamma decreases the adhesiveness and invasiveness of prostate cancer cells].

Gao L, Yang DJ, Lin XG, Xu WH, Wang XM. Gao L, et al. Among authors: xu wh. Zhonghua Nan Ke Xue. 2008 Jun;14(6):513-6. Zhonghua Nan Ke Xue. 2008. PMID: 18649748 Chinese.

3

MicroRNA-495 Regulates Migration and Invasion in Prostate Cancer Cells Via Targeting Akt and mTOR Signaling.

Li JZ, Wang ZL, Xu WH, Li Q, Gao L, Wang ZM. Li JZ, et al. Among authors: xu wh. Cancer Invest. 2016;34(4):181-8. doi: 10.3109/07357907.2016.1156690. Epub 2016 Mar 31. Cancer Invest. 2016. PMID: 27031291

4

Neoadjuvant therapy with camrelizumab plus gemcitabine and cisplatin for patients with muscle-invasive bladder cancer: A multi-center, single-arm, phase 2 study.

Han S, Ji Z, Jiang J, Fan X, Ma Q, Hu L, Zhang W, Ping H, Wang J, Xu W, Shi B, Wang W, Wang H, Wang H, Chen S, Hu H, Guo J, Zhang S, Jiang S, Zhou Q, Xing N. Han S, et al. Cancer Med. 2023 Jun;12(11):12106-12117. doi: 10.1002/cam4.5900. Epub 2023 Apr 6. Cancer Med. 2023. PMID: 37021811 Free PMC article. Clinical Trial.

5

Current and Potential Roles of Ferroptosis in Bladder Cancer.

An WX, Gupta R, Zhai K, Wang YR, Xu WH, Cui Y. An WX, et al. Among authors: xu wh. Curr Med Sci. 2024 Feb;44(1):51-63. doi: 10.1007/s11596-023-2814-6. Epub 2023 Dec 7. Curr Med Sci. 2024. PMID: 38057536 Review.

6

Single-cell analyses EMP1 as a marker of the ratio of M1/M2 macrophages is associated with EMT, immune infiltration, and prognosis in bladder cancer.

Li J, Liu J, Wang H, Ma J, Wang Y, Xu W. Li J, et al. Bladder (San Franc). 2023 Dec 18;10:e21200011. doi: 10.14440/bladder.2023.852. eCollection 2023. Bladder (San Franc). 2023. PMID: 38163006 Free PMC article.

7

Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma.

Qiao ZK, Li YL, Lu HT, Wang KL, Xu WH. Qiao ZK, et al. Among authors: xu wh. World J Surg Oncol. 2013 Jan 3;11:1. doi: 10.1186/1477-7819-11-1. World J Surg Oncol. 2013. PMID: 23281640 Free PMC article.

8

miR-5089-5p suppresses castration-resistant prostate cancer resistance to enzalutamide and metastasis via miR-5089-5p/SPINK1/ MAPK/MMP9 signaling.

Wang ZC, Li Y, Wang KL, Wang L, You BS, Zhao DF, Liu ZQ, Fang RZ, Wang JQ, Zhang W, Zhang JM, Xu WH. Wang ZC, et al. Among authors: xu wh. Aging (Albany NY). 2020 Jul 21;12(14):14418-14433. doi: 10.18632/aging.103485. Epub 2020 Jul 21. Aging (Albany NY). 2020. PMID: 32694237 Free PMC article. Retracted.

9

Multi-omics comprehensive analysis reveals the predictive value of N6-methyladenosine- related genes in prognosis and immune escape of bladder cancer.

Liu Y, Pang Z, Wang J, Wang J, Ji B, Xu Y, He J, Zhang L, Han Y, Shen L, Xu W, Ren M. Liu Y, et al. Cancer Biomark. 2024;40(1):79-94. doi: 10.3233/CBM-230286. Cancer Biomark. 2024. PMID: 38517777

10

A Transformable Specific-Responsive Peptide for One-Step Synergistic Therapy of Bladder Cancer.

Wang ZQ, Qu TR, Zhang ZS, Zeng FS, Song HJ, Zhang K, Guo P, Tong Z, Hou DY, Liu X, Wang L, Wang H, Xu W. Wang ZQ, et al. Small. 2024 Apr 25:e2310416. doi: 10.1002/smll.202310416. Online ahead of print. Small. 2024. PMID: 38660815

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

661 results

Search Page